tretinoin and 1-arabinofuranosylcytosine-5--stearylphosphate

tretinoin has been researched along with 1-arabinofuranosylcytosine-5--stearylphosphate* in 1 studies

Other Studies

1 other study(ies) available for tretinoin and 1-arabinofuranosylcytosine-5--stearylphosphate

Article	Year
Combination therapy with granulocyte colony-stimulating factor, all-trans retinoic acid, and low-dose cytotoxic drugs for acute myelogenous leukemia. Internal medicine (Tokyo, Japan), 1995, Volume: 34, Issue:12 A 67-year-old man presented with acute myelogenous leukemia (M2). Peripheral blood examination revealed a leukocyte count of 1,700/mu l with 1% myeloblasts, and bone marrow aspiration showed 42.6% myeloblasts with Auer bodies. Culture of his marrow cells at diagnosis showed that granulocyte colony-stimulating factor (G-CSF) promoted cell proliferation, while all-trans retinoic acid (ATRA) inhibited the proliferative effect of G-CSF and induced differentiation. Combination therapy with G-CSF, ATRA, and low-dose cytotoxic drugs achieved complete remission without severe marrow suppression. Topics: Aged; Antineoplastic Agents; Arabinonucleotides; Bone Marrow; Cyclophosphamide; Cytidine Monophosphate; Drug Therapy, Combination; Granulocyte Colony-Stimulating Factor; Humans; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Male; Tretinoin	1995

Article

Year

Combination therapy with granulocyte colony-stimulating factor, all-trans retinoic acid, and low-dose cytotoxic drugs for acute myelogenous leukemia.

Internal medicine (Tokyo, Japan), 1995, Volume: 34, Issue:12

A 67-year-old man presented with acute myelogenous leukemia (M2). Peripheral blood examination revealed a leukocyte count of 1,700/mu l with 1% myeloblasts, and bone marrow aspiration showed 42.6% myeloblasts with Auer bodies. Culture of his marrow cells at diagnosis showed that granulocyte colony-stimulating factor (G-CSF) promoted cell proliferation, while all-trans retinoic acid (ATRA) inhibited the proliferative effect of G-CSF and induced differentiation. Combination therapy with G-CSF, ATRA, and low-dose cytotoxic drugs achieved complete remission without severe marrow suppression.

Topics: Aged; Antineoplastic Agents; Arabinonucleotides; Bone Marrow; Cyclophosphamide; Cytidine Monophosphate; Drug Therapy, Combination; Granulocyte Colony-Stimulating Factor; Humans; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Male; Tretinoin

1995